Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (311-320 of 627) with videos related to

Pageof 63
Sort By:
Lancet (London, England)|March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II studyRichard C Becker, David J Moliterno, Lisa K Jennings, et al.
American Heart Journal|May 13, 2015
Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Fredrik Holmqvist, Ni Guan, Zhaoyin Zhu, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
JAMA Cardiology|December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION TrialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology|May 21, 2013
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trendsPierluigi Tricoci, Sergio Leonardi, Jennifer White, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2013
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injuryDiederik W D Kuster, Adriana Cardenas-Ospina, Lawson Miller, et al.
Journal of General Internal Medicine|January 16, 2008
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Qinghong Yang, Karen S Pieper, et al.
International Journal of Cardiology|August 27, 2018
Incremental prognostic value of renal function for stroke prediction in atrial fibrillationEmily C O'Brien, DaJuanicia N Holmes, Laine Thomas, et al.
JAMA|January 27, 2000
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Sparapani, K W Mahaffey, et al.
American Heart Journal|April 29, 2014
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Gregg C Fonarow, et al.
Pageof 63

Showing results (311-320 of 627) with videos related to

Sort By:
Pageof 63
Lancet (London, England)|March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II studyRichard C Becker, David J Moliterno, Lisa K Jennings, et al.
American Heart Journal|May 13, 2015
Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Fredrik Holmqvist, Ni Guan, Zhaoyin Zhu, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
JAMA Cardiology|December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION TrialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology|May 21, 2013
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trendsPierluigi Tricoci, Sergio Leonardi, Jennifer White, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2013
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injuryDiederik W D Kuster, Adriana Cardenas-Ospina, Lawson Miller, et al.
Journal of General Internal Medicine|January 16, 2008
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Qinghong Yang, Karen S Pieper, et al.
International Journal of Cardiology|August 27, 2018
Incremental prognostic value of renal function for stroke prediction in atrial fibrillationEmily C O'Brien, DaJuanicia N Holmes, Laine Thomas, et al.
JAMA|January 27, 2000
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Sparapani, K W Mahaffey, et al.
American Heart Journal|April 29, 2014
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Gregg C Fonarow, et al.
Pageof 63